Monteverde & Associates PC, a class action law firm, is investigating the fairness of recent mergers and sales involving Range Resources Corporation (RRC), Surgery Partners, Inc. (SGRY), Bolt Biotherapeutics, Inc. (BOLT), and Pacira BioSciences, Inc. (PCRX). Shareholders of these companies are offered specific stock or cash deals, and the firm is assessing whether these transactions are fair. The investigation is free for shareholders, with no obligation, and aims to protect shareholder interests in these deals. Investors can contact the firm for more information or legal assistance.
Range Resources Corporation (RRC) shares are trading at USD 54.27 on Pluang as of Nov 04, 2026 20:31 WIB, close to their 52-week high of USD 56.36. The stock has seen a modest 1-day gain of 0.47%, contrasting with a 52-week low of USD 33.43, indicating a relatively strong position in its yearly range. Despite this, Pluang order activity shows a full 100% sell interest, suggesting cautious sentiment among platform users.
Halper Sadeh LLC is investigating potential legal violations and fiduciary breaches related to the sales and mergers of Surgery Partners, Range Resources, and First Community Bankshares. The firm highlights that insiders may gain financial benefits n...
Brodsky & Smith LLC has announced investigations into the merger agreements of four companies: Lumentum Holdings, Surgery Partners, Range Resources, and American Oncology Network. These investigations focus on whether the boards of these companies br...
